LEADERS FREE 2
To demonstrate that the BioFreedomTM Drug Coated Stent is non-inferior to the Gazelle™ BMS arm of the Leaders Free study in high bleeding risk patients treated with one month DAPT only
The composite of cardiac death and myocardial infarction at 1 year
The incidence of clinically driven target lesion revascularization at 1 year
- Core Laboratory
85 sites in total distributed throughout Europe and North America (US and Canada). CERC is responsible for the European sites. These are distributed by 5 countries: France, Denmark, Germany, UK and Italy.
16 centers managed by CERC.